Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-02
1998-12-29
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31425
Patent
active
058542671
ABSTRACT:
A method for preventing heartburn episodes in a patient susceptible to suffering heartburn episodes following ingestion of heartburn-inducing food or beverage, comprising administering to the patient, 30 minutes prior to consumption by the patient of the food or beverage, a composition comprising an amount of famotidine of 10 mg.
REFERENCES:
patent: 4283408 (1981-08-01), Hirata et al.
Pepcid AC acid Control-Product Monograph, pp. 1-32 (1994).
Yamada, "Textbook of Gastroenterology", vol. 1, pp. 1214, 1215, and 1232 (1995).
Chremos, A.N., "Clinical Pharmacology of Famotidine: A Summary", J. Clin. Gastroenterol, vol. 9 (Suppl. 2), pp. 7-12 (1987).
Thompson et al., "Heartburn and globus in apparently healthy people", CMA Journal, vol. 126, pp. 46-48 (1982).
Laskin et al., "Pharmacodynamics and Dose-Response Relationship of Famotidine: A Double-Blind Randomized Placebo-Controlled Trial", J. Clin. Pharmacol, vol. 33, pp. 636-639 (1993).
McCallum et al., "MK-208, A Novel Histamine H2-Receptor Inhibitor with Prolonged Antisecretory Effect", Digestive Diseases and Sciences, vol. 30, pp. 1139-1144 (1985).
Gitlin et al., "A Multiclinic Double-Blind Dose Ranging Study Evaluating the Efficacy and Safety of Famotidine in the Healing of Active Duodenal Ulcer as compared to Placebo", Amer. Journal of Gastroenterology, vol. 80, p. 840 (1985).
Miyoshi et al., "Clinical Evaluation of Famotidine on Acute Gastric Mucosal Lesions Associated with Acute Gastritis and Chronic Gastritis-Dose Finding Study by the Double Blind Comparative Method-", Naika Hokan, vol. 34, pp. 442-457.
Douds, Andrew C. and J. Douglas Maxwell, "Over the Counter H2 receptor Antagonists", BMJ, (Letters), vol. 309, p. 1156 (1994).
Cooper, J.R.B., "Increase the risks to offshore workers", BMJ, (Letters), vol. 309, pp. 1156-1157 (1994).
Simon et al., "Self-Directed Treatment of Intermittent Heartburn: A Randomized, Multicenter, Double-Blind(DB), Placebo(P)-Controlled Evaluation of Famotidine(FAM) 5, 10 & 20MG and Antacid(AA)", Esophageal, Gastric, and Duodenal Disorders, p. A181 (1994).
MSD Merck Sharp & Dohme, "Pepcid Insert" 1986.
Stedman's Medical Dictionary (1995) p. 356, Pub. Houghton Mifflin Company.
Koss et al., Gastroenterology, 98(6) A71 (1990).
Simon et al., Gastroenterology 106(4 Suppl.) 1994.
Berlin Roger
Gates Thomas N.
Simon Thomas
Mc Neil-PPC, Inc.
Merck & Co. , Inc.
Parr Richard S.
Spivack Phyllis G.
Winokur Melvin
LandOfFree
Method for preventing heartburn does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing heartburn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing heartburn will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1425170